Who are LIGAND PHARMACEUTICALS INC's main suppliers?

LIGAND PHARMACEUTICALS INC (LGNZZ) key suppliers include: Dianthus Therapeutics, Inc., Viking Therapeutics, Inc.. View the full supplier network at chainsifter.com/chain/LGNZZ.

Who are LIGAND PHARMACEUTICALS INC's major customers?

LIGAND PHARMACEUTICALS INC (LGNZZ) key customers include: Dianthus Therapeutics, Inc., Viking Therapeutics, Inc.. View the full customer network at chainsifter.com/chain/LGNZZ.

What sector is LIGAND PHARMACEUTICALS INC in?

LIGAND PHARMACEUTICALS INC (LGNZZ) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

LIGAND PHARMACEUTICALS INC (LGNZZ) Suppliers & Customers

2Suppliers

2Customers

2Debt Items

19Related Chains

Source-Backed Evidence Depth

LIGAND PHARMACEUTICALS INC (LGNZZ) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

6Total relationships

0Distinct source URLs

2High confidence

0.780Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

LIGAND PHARMACEUTICALS INC Suppliers

Ticker	Name	Confidence	Evidence
DNTH	Dianthus Therapeutics, Inc.	72%	Reciprocal relationship from DNTH graph: Reciprocal relationship from LGNZZ graph: Reciprocal relationship from DNTH graph: tents Cash Flows from Financing Activities For the year ended December 31, …
VKTX	Viking Therapeutics, Inc.	72%	Reciprocal relationship from VKTX graph: from non-elective hip fracture surgery. However, VK5211, if approved, will face competition from experimental therapies that are in various stages of clinical…

LIGAND PHARMACEUTICALS INC Customers

Ticker	Name	Confidence	Evidence
DNTH	Dianthus Therapeutics, Inc.	72%	Reciprocal relationship from DNTH graph: tents Cash Flows from Financing Activities For the year ended December 31, 2024, net cash provided by financing activities consisted of $215.3 million of net …
VKTX	Viking Therapeutics, Inc.	72%	Reciprocal relationship from VKTX graph: Reciprocal relationship from LGNZZ graph: Reciprocal relationship from VKTX graph: from non-elective hip fracture surgery. However, VK5211, if approved, will …

LIGAND PHARMACEUTICALS INC Debt Obligations

Instrument	Description	Confidence	Evidence
LGNZZ-DEBT-10695	Warrants outstanding: 3264643	90%	xbrl warrant detail from xbrl 2023-12-31.
LGNZZ-DEBT-10696	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.

LIGAND PHARMACEUTICALS INC Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for LIGAND PHARMACEUTICALS INC.

LIGAND PHARMACEUTICALS INC Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for LIGAND PHARMACEUTICALS INC.

LIGAND PHARMACEUTICALS INC Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
VKTX	Viking Therapeutics, Inc.	100.00	1	['customer', 'supplier']
DNTH	Dianthus Therapeutics, Inc.	100.00	1	['customer', 'supplier']
BHC	Bausch Health Companies Inc.	50.00	2
ORANY	ORANGE	50.00	2
GYRE	Gyre Therapeutics, Inc.	50.00	2
ALNY	Alnylam Pharmaceuticals, Inc.	50.00	2
ARWR	Arrowhead Pharmaceuticals, Inc.	50.00	2
GPCR	Structure Therapeutics Inc.	50.00	2
IBIO	iBio, Inc.	50.00	2
HEPA	Hepion Pharmaceuticals, Inc.	50.00	2
MDGL	Madrigal Pharmaceuticals, Inc.	50.00	2
SEPN	Septerna, Inc.	50.00	2
SNYNF	Sanofi	50.00	2
TERN	Terns Pharmaceuticals, Inc.	50.00	2
MTVA	MetaVia Inc.	50.00	2
GLMD	Galmed Pharmaceuticals Ltd.	50.00	2
CRBP	Corbus Pharmaceuticals Holdings, Inc.	50.00	2
ZBIO	Zenas BioPharma, Inc.	50.00	2
LGND	Ligand Pharmaceuticals Incorporated	50.00	2

LIGAND PHARMACEUTICALS INC Supply Chain